Our data show a substantial higher OS in patients transplanted after 2005, which did not reach statistical significance, but is supported by the notion that experience in ASCT influences outcomes, and thus is relevant when comparing transplant results over decades and, importantly, when putting our study in the context of more recent trials on non-transplant treatments in STS. 27 28 Median PFS and OS of the total population of our study were 8.3 and 19.8 months, respectively.
← all excerpts
Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation.
1
—
—